Location History:
- Vaumarcus, CH (2009)
- Troinex, CH (2007 - 2010)
Company Filing History:
3 out of 136 
2 out of 156 
1 out of 1,168 Years Active: 2007-2010
Title: The Innovative Contributions of Ursula Boschert
Introduction
Ursula Boschert is a notable inventor based in Troinex, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of cytokine antagonist molecules. With a total of 6 patents to her name, her work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
One of her latest patents is a method of treatment comprising the administration of a cytokine antagonist molecule. This invention relates to novel uses of a protein sequence identified as INSP052EC, which is crucial in the diagnosis, prevention, and treatment of diseases associated with excessive expression and/or secretion of cytokines. Another significant patent involves a novel protein, INSP052, which is also identified as an immunoglobulin domain-containing cell surface recognition molecule. This invention focuses on the use of this protein and its nucleic acid sequences in the diagnosis, prevention, and treatment of diseases, along with the identification of the extracellular domain of INSP052.
Career Highlights
Throughout her career, Ursula has worked with various companies, including Ares Trading S.A. and Applied Research Systems Ars Holding N.V. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.
Collaborations
Ursula has collaborated with notable individuals in her field, including Richard Fagan and Christopher Benjamin Phelps. These collaborations have likely enriched her research and innovation efforts.
Conclusion
Ursula Boschert's contributions to biotechnology through her patents and collaborations highlight her role as a significant inventor in her field. Her work continues to pave the way for advancements in medical treatments and diagnostics.